Ramsay Health Care Ltd (ASX: RHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ramsay Health Care Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $8.28 billion
P/E Ratio 337.95
Dividend Yield 2.26%
Shares Outstanding 230.83 million
Earnings per share 0.105
Dividend per share 0.80
Year To Date Return 2.88%
Earnings Yield 0.30%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Ramsay Health Care Ltd (ASX: RHC)
    Latest News

    a woman
    Share Market News

    Top broker says Ramsay Health Care Limited (ASX:RHC) shares are a sell

    Should you sell Ramsay Health Care Limited (ASX:RHC) shares? This top broker thinks you should...

    Read more »

    a woman
    Defensive Shares

    3 high quality blue chips I want to buy

    These 3 blue chips are high quality, I want to buy them.

    Read more »

    a woman
    Share Market News

    Why another top broker just upgraded Primary Health Care Limited (ASX:PRY) to "buy"

    The worse of the sell-off in Primary Health Care Limited (ASX:PRY) could be well behind us even as management warned…

    Read more »

    a woman
    Share Market News

    The private hospital sector is under pressure

    Private hospitals face a difficult period.

    Read more »

    a woman
    Growth Shares

    2 companies cashing in on the ageing population

    Challenger Ltd (ASX:CGF) and Ramsay Health Care Limited (ASX:RHC) look well-positioned to benefit from the increasing headcount of older Australians.

    Read more »

    a woman
    Share Market News

    Top broker says sell Ramsay Health Care Limited (ASX:RHC) and buy ResMed Inc (ASX:RMD) shares

    Goldman Sachs has named Ramsay Health Care Limited (ASX:RHC) as a sell and ResMed Inc (ASX:RMD) shares as a buy.…

    Read more »

    a woman
    Share Market News

    5 things to watch on the ASX on Tuesday

    The shares of Clearview Wealth Ltd (ASX:CVW), Ramsay Health Care Limited (ASX:RHC), and ResMed Inc. (ASX:RMD) will be on watch…

    Read more »

    a woman
    Share Market News

    Another common stock market mistake to avoid: "The market's crashing – I've gotta get out!"

    The other week, in my article, "4 Common Mistakes Millennials make Stock Market Investing"  I began to answer some of…

    Read more »

    a woman
    Growth Shares

    A quick check-up on these 3 S&P/ASX 200 healthcare stocks

    Here’s a quick check-up on three well-known health stocks.

    Read more »

    a woman
    Share Market News

    Is the Ramsay Health Care Limited (ASX:RHC) share price a buy?

    The Ramsay Health Care Limited (ASX:RHC) share price is getting more attractive.

    Read more »

    a woman
    Share Market News

    The 3 biggest disappointments during earnings season

    The G8 Education Ltd (ASX:GEM) result was one of three major disappointments during earnings season…

    Read more »

    a woman
    ⏸️ ASX Shares

    Should you buy Ramsay Health Care Limited (ASX:RHC) shares?

    The Ramsay Health Care Limited (ASX:RHC) share price fell heavily on Thursday. Is this a buying opportunity?

    Read more »

    Frequently Asked Questions

    Yes, Ramsay Health Care has historically paid two fully franked dividends a year.

    Ramsay Health Care generally pays its shareholder dividends in March and September. 

    Ramsay Health Care Ltd listed on the ASX on 24 September 1997.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    03 Sep 2025 $0.4000 100.00% Final 25 Sep 2025
    06 Mar 2025 $0.4000 100.00% Interim 27 Mar 2025
    04 Sep 2024 $0.4000 100.00% Final 26 Sep 2024
    11 Mar 2024 $0.4000 100.00% Interim 05 Apr 2024
    06 Sep 2023 $0.2500 100.00% Final 29 Sep 2023
    06 Mar 2023 $0.5000 100.00% Interim 30 Mar 2023
    05 Sep 2022 $0.4850 100.00% Final 29 Sep 2022
    07 Mar 2022 $0.4850 100.00% Interim 31 Mar 2022
    06 Sep 2021 $1.0300 100.00% Final 30 Sep 2021
    08 Mar 2021 $0.4850 100.00% Interim 31 Mar 2021
    05 Mar 2020 $0.6250 100.00% Interim 27 Mar 2020
    05 Sep 2019 $0.9150 100.00% Final 30 Sep 2019
    06 Mar 2019 $0.6000 100.00% Interim 29 Mar 2019
    05 Sep 2018 $0.8650 100.00% Final 28 Sep 2018
    06 Mar 2018 $0.5750 100.00% Interim 29 Mar 2018
    05 Sep 2017 $0.0000 100.00% Final 28 Sep 2017
    07 Mar 2017 $0.5300 100.00% Interim 29 Mar 2017
    06 Sep 2016 $0.7200 100.00% Final 29 Sep 2016
    08 Mar 2016 $0.4700 100.00% Interim 30 Mar 2016
    08 Sep 2014 $0.5100 100.00% Final 24 Sep 2014
    04 Mar 2014 $0.3400 100.00% Interim 26 Mar 2014
    03 Sep 2013 $0.4150 100.00% Final 25 Sep 2013
    04 Mar 2013 $0.2900 100.00% Interim 27 Mar 2013
    05 Mar 2012 $0.2550 100.00% Interim 28 Mar 2012
    02 Sep 2011 $0.2950 100.00% Final 26 Sep 2011
    08 Mar 2011 $0.2250 100.00% Interim 28 Mar 2011
    31 Aug 2010 $0.2500 100.00% Final 27 Sep 2010
    16 Mar 2010 $0.1850 100.00% Interim 09 Apr 2010
    21 Sep 2009 $0.2150 100.00% Final 09 Oct 2009
    20 Mar 2009 $0.1650 100.00% Interim 08 Apr 2009
    25 Sep 2008 $0.1750 100.00% Final 15 Oct 2008
    26 Sep 2007 $0.1600 100.00% Final 12 Oct 2007
    27 Mar 2006 $0.1050 100.00% Interim 12 Apr 2006
    26 Sep 2005 $0.1150 100.00% Final 14 Oct 2005
    16 Apr 2004 $0.0750 100.00% Interim 30 Apr 2004

    RHC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ramsay Health Care Ltd

    Ramsay Health Care Ltd (ASX: RHC) is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia. 

    As well as private hospitals, Ramsay operates day surgeries, primary care clinics, diagnostic and imaging centres, mental health facilities, pharmacies, and an expanding range of in-home and community care services.

    It is the largest private hospital group in Australia, France, and the Scandanavian countries. Its 52.5%-owned subsidiary Ramsay Sante oversees its European operations. Its UK business includes mental health facilities and a range of clinical specialties.

    The vast majority of the company's revenue is generated from its Australian and European operations.

    RHC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Jan 2026 $35.88 $-0.07 -0.19% 396,960 $36.19 $36.62 $35.88
    12 Jan 2026 $35.95 $0.60 1.70% 280,470 $35.40 $36.01 $35.39
    09 Jan 2026 $35.35 $-0.33 -0.92% 385,048 $35.68 $35.99 $35.26
    08 Jan 2026 $35.68 $0.75 2.15% 392,670 $34.75 $35.81 $34.75
    07 Jan 2026 $34.93 $-0.02 -0.06% 441,525 $34.95 $35.17 $34.74
    06 Jan 2026 $34.95 $0.04 0.11% 412,448 $34.83 $35.07 $34.53
    05 Jan 2026 $34.91 $0.32 0.93% 246,148 $34.50 $34.93 $34.50
    02 Jan 2026 $34.59 $0.23 0.67% 151,659 $34.43 $34.79 $34.38
    31 Dec 2025 $34.36 $-0.08 -0.23% 238,767 $34.69 $34.69 $34.27
    30 Dec 2025 $34.44 $-0.12 -0.35% 305,939 $34.75 $34.85 $34.39
    29 Dec 2025 $34.56 $-0.63 -1.79% 293,985 $35.47 $35.47 $34.43
    24 Dec 2025 $35.19 $-0.32 -0.90% 142,822 $35.17 $35.41 $35.11
    23 Dec 2025 $35.51 $1.00 2.90% 437,212 $34.77 $35.72 $34.71
    22 Dec 2025 $34.51 $-0.09 -0.26% 266,143 $34.50 $34.97 $34.38
    19 Dec 2025 $34.60 $0.50 1.47% 1,859,246 $34.03 $34.60 $33.90
    18 Dec 2025 $34.10 $-0.14 -0.41% 511,488 $34.15 $34.21 $33.78
    17 Dec 2025 $34.24 $-0.66 -1.89% 401,668 $34.92 $34.92 $34.17
    16 Dec 2025 $34.90 $-0.45 -1.27% 747,574 $35.05 $35.48 $34.69

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Dec 2025 Natalie Davis Issued 74,075 $2,618,551
    Issue of securities. 131,547 Performance Rights
    26 Nov 2025 Natalie Davis Issued 21,071 $675,011
    Director remuneration. VWAP

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Ingle Thodey Non-Executive DirectorNon-Executive Chairman Nov 2017
    Mr Thodey is a business leader focused on innovation, technology, digital transformation, and corporate governance, with more than 40 years of experience. In addition to being Chair he is currently Chair of Xero Limited, Chancellor the University of Sydney, and co-Chair of the Great Barrier Reef Foundation. He is also a non-executive member of the Reserve Bank of Australia Governance Board. He is Chair of Governance Committee.
    Ms Catriona Alison Deans Non-Executive Director Nov 2018
    Ms Deans has 25 years of experience building technology-enabled businesses involved in media, ecommerce, financial services, and health, and across leadership roles as an executive, a director and in venture capital. She is also Chair of Cochlear Limited, Chair of Calix Limited and a Non-Executive Director of Fitness Passport, The Observership Program and Deputy Pty Ltd. She is also a Venture Partner of Main Sequence Ventures. In her executive career, she was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas and most recently CEO of Netus Pty Ltd (a technology investment company acquired by Fairfax). She also spent seven years as a consultant with McKinsey and Company. She is also a member of Governance Committee.
    Mr Michael Stanley Siddle Non-Executive Director May 1975
    Mr Siddle has experience in the management of private hospitals and has been involved in expansion through developments, mergers and acquisitions. He is also member of Governance Committee.
    Mr Craig Milton Drummond Non-Executive Director Jul 2025
    Mr Drummond brings executive and board-level experience across healthcare, financial services, and other regulated industries. He is also Chair of Transurban Group, Chair of the Australian Foundation Investment Company Limited, and Chair of The Ian Potter Foundation. He has previously served as President and Director of the Geelong Football Club Ltd, a Director of the Florey Institute of Neuroscience and Mental Health, and a Member of the Federal Government's Financial Regulator Assessment Authority. His executive career includes five years as Chief Executive Officer of Medibank Private Ltd (2016-2021). He was formerly Group Executive Finance and Strategy at National Australia Bank, and Chief Executive Officer and Country Head at Bank of America Merrill Lynch (Australia).
    Ms Helen Kurincic Non-Executive Director Mar 2024
    Ms Kurincic is member of Risk Management Committee. She brings operational, executive and board-level experience in a range of Australian based healthcare organisations. In addition to serving on the Ramsay Board, she is currently Chair of McMillan Shakespeare and a director of Carlton Football Club. Her previous health sector roles include Non-Executive Director of private health insurer HBF Health, Estia Health, Integral Diagnostics (Chair), Sirtex Medical, Domain Principal Group, public hospital service provider Melbourne Health, Orygen Youth Mental Health Research Centre and DCA Group.
    Ms Karen Lee Collett Penrose Non-Executive Director Mar 2020
    Ms Penrose is member of Risk Management Committee. She has had an executive career in leadership and CFO roles, in financial services. She has experience in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. She has been a full-time director since 2014 and is a committee chair of audit and risk.
    Mr Steven Andrew Sargent Non-Executive Director Nov 2021
    Mr Sargent is Chair of Risk Management Committee. His executive career included 22 years at General Electric, where he gained multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe, and Asia Pacific. In addition to being a Non-Executive Director of Ramsay, he also serves as a Director of Ramsay Generale de Sante and is the Chair of infection prevention company Nanosonics Limited. His unlisted board activities include Chairman of The Origin Foundation Limited, Origin's philanthropic arm, and Non-Executive Director of The Great Barrier Reef Foundation.
    Ms Claudia Ricarda Rita Sussmuth Dyckerhoff Non-Executive Director Oct 2018
    Ms Dyckerhoff brings expertise in market growth strategies, business development and operational performance improvement in hospitals. She has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey & Company in Switzerland in 1995 and transferred to the USA focusing on supporting health care companies, including pharmaceutical/medical device companies, payor, provider and health systems in Europe and the USA. In 2006, she transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She is member of Risk Management Committee.
    Mr Natalie Davis Chief Executive OfficerManaging Director Dec 2024
    Ms Davis has experience driving strategic transformation, customer focus and growth. She joined Ramsay after a decade with the Woolworths Group, where she held several roles including as Managing Director of Woolworths Supermarkets, Chief Customer Transformation Officer and Managing Director Woolworths NZ.
    Ms Henrietta Rowe Company SecretaryGroup General Counsel Jun 2019
    -
    Michael Hirner Acting Group Executive Finance
    -
    Henrietta Rowe Company SecretaryGroup General Counsel
    -
    Brindan Suresh Group Executive Health and Strategy
    -
    Colleen Harris Group Executive People and Sustainability
    -
    Pascal Roche Managing Director Ramsay Sante
    -
    Nick Costa Managing Director UK Hospitals Acting Managing Director Elysium
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 48,815,874 21.15%
    J P Morgan Nominees Australia Pty Limited 36,515,720 15.82%
    Netwealth Investments Limited <Wrap Services A/C> 33,792,188 14.64%
    Paul Ramsay Holdings Pty Limited 22,346,876 9.68%
    Citicorp Nominees Pty Limited 8,187,680 3.55%
    National Nominees Limited 7,230,630 3.13%
    Woolwich Investments Pty Ltd <The Siddle Family Trust> 3,238,259 1.40%
    BNP Paribas Noms Pty Ltd 3,147,220 1.36%
    Washington H Soul Pattinson And Company Limited 2,758,806 1.20%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 2,750,000 1.19%
    Argo Investments Limited 2,747,673 1.19%
    BNP Paribas Nominees Pty Ltd <Agency Lending Collateral > 2,721,314 1.18%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 2,057,299 0.89%
    Custodial Services Limited <Beneficiaries Holding A/C> 1,028,000 0.45%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 780,296 0.34%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 721,395 0.31%
    HSBC Custody Nominees (Australia) Limited Gsi Eda 710,830 0.31%
    Australian Foundation Investment Company Limited 625,740 0.27%
    UBS Nominees Pty Ltd 575,000 0.25%
    Certane Ct Pty Ltd <Ramsay Unallocated Ac> 574,899 0.25%

    Profile

    since

    Note